Picture1

WuXi Global Forum 2023

<a href="#hui-cai">Hui Cai</a>, Program Chair, VP and Head of Content, WuXi AppTec

Welcome

<a href="#cara-altimus">Cara Altimus</a>, Senior Director, Center for Strategic Philanthropy, Milken Institute 
<a href="#daniel-fung">Daniel Fung</a>, CEO, Institute of Mental Health in Singapore 
<a href="#john-krystal">John Krystal</a>, Chair, Department of Psychiatry; Robert L. McNeil, Jr. Professor of Translational Research, Yale University

Urgent Attention to Address Mental Health

<a href="#john-dunlop">John Dunlop</a>, Head of Research &amp; Development, Neumora 
<a href="#murali-gopalakrishnan">Murali Gopalakrishnan</a>, Global Head, Neuroscience Search &amp; Evaluation, Corporate Strategy Office, AbbVie 
<a href="#barry-greene">Barry Greene</a>, CEO and Member of Board of Directors, Sage Therapeutics 
<a href="#ekaterina-malievskaia">Ekaterina Malievskaia</a>, Co-Founder &amp; Chief Innovation Officer, COMPASS Pathways 
<a href="#brigitte-(bigs)-robertson">Brigitte (Bigs) Robertson</a>, CMO, Delix Therapeutics 
Moderator: <a href="#lauren-martz">Lauren Martz</a>, Executive Director, Biopharma Intelligence, BioCentury

Latest Therapeutic Developments in Mental Health

<a href="#ben-robbins">Ben Robbins</a>, General Partner, GV 
<a href="#daphne-zohar">Daphne Zohar</a>, Founder &amp; CEO, PureTech Health

Challenges and Opportunities towards the Future of Mental Health Care 

<a href="#richard-soll">Richard Soll</a>, Head of Boston Office and Senior Advisor of Strategic Initiatives, WuXi AppTec

Closing Remarks

mental health banner_2

Mental Health R&D: A Global Priority

<a href="#hui-cai">Hui Cai</a>, Program Chair, VP and Head of Content, WuXi AppTec 
<a href="#katie-clapp">Katie Clapp</a>, President &amp; Co-Founder, FRAXA Research Foundation

Welcome 

<a href="#elizabeth-berry-kravis">Elizabeth Berry-Kravis</a>, Professor of Pediatrics, Neurological Sciences, Anatomy and Cell Biology, Rush University Medical Center 
<a href="#peter-kind">Peter Kind</a>, Director, Simons Initiative for the Developing Brain, Patrick Wild Centre; Professor of Developmental Neuroscience, University of Edinburgh 
Session Leader: <a href="#michael-tranfaglia">Michael Tranfaglia</a>, Medical Director &amp; CSO, FRAXA Research Foundation

Opening Plenary

Hosts: <a href="#wendy-bruce">Wendy Bruce</a>, Executive Director, Fragile X Association of Australia, and <a href="#jeannie-lee">Jeannie Lee</a>, Vice Chair of Molecular Biology, MGH; Professor of Genetics, Harvard Medical School. 
<a href="#david-hampson">David Hampson</a>, Professor, Department of Pharmaceutical Sciences, University of Toronto 
<a href="#ralph-laufer">Ralph Laufer</a>, CSO, Lysogene 
<a href="#ernest-pedapati">Ernest Pedapati</a>, Associate Professor, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine 
<a href="#kathryn-whitehead">Kathryn Whitehead</a>, Professor, Departments of Chemical Engineering and Biomedical Engineering, Carnegie Mellon University

Innovation Showcase I: Gene Therapy/Gene Reactivation/Protein Replacement 

Hosts: <a href="#mark-bear">Mark Bear</a>, Professor of Neuroscience, Picower Institute for Learning and Memory, MIT, and <a href="#craig-erickson">Craig Erickson</a>, Professor of Clinical Psychiatry, Cincinnati Children&#8217;s Hospital and the University of Cincinnati College of Medicine. 
<a href="#daniel-alkon">Daniel Alkon</a>, President, CSO &amp; Scientific Founder, Synaptogenix 
<a href="#john-atack">John Atack</a>, Director, Medicines Discovery Institute, Cardiff University 
<a href="#mara-dierssen">Mara Dierssen</a>, Senior Scientist, Center for Genomic Regulation 
<a href="#lynn-durham">Lynn Durham</a>, Founder &amp; CEO, STALICLA 
<a href="#lili-mao">Lili Mao</a>, Head of Project Management Office and Director, Clinical Development Unit, GEXVal 
<a href="#christopher-missling">Christopher Missling</a>, President &amp; CEO, Anavex Life Sciences 
<a href="#adrian-newman-tancredi">Adrian Newman-Tancredi</a>, CEO, Neurolixis 
<a href="#stephen-o'quinn">Stephen O&#8217;Quinn</a>, VP, Medical Affairs, Zynerba Pharmaceuticals 
<a href="#robert-ring">Robert Ring</a>, CEO, Kaerus Bioscience 
<a href="#fabio-tucci">Fabio Tucci</a>, COO &amp; Co-Founder, Epigen Biosciences 
<a href="#david-walker">David Walker</a>, Director of Chemistry, Sentinel Oncology

Innovation Showcase II: Targeted Therapy 

Hosts: <a href="#bruce-bloom">Bruce Bloom</a>, Chief Collaboration Officer, Healx, and <a href="#andres-centellas">Andres Centellas</a>, Board Member, FRAXA Research Foundation. 
<a href="#isaac-bentwich">Isaac Bentwich</a>, Founder &amp; CEO, Quris 
<a href="#randall-carpenter">Randall Carpenter</a>, Co-Founder, Allos Pharma 
<a href="#george-drakakis">George Drakakis</a>, CEO, Purposeful 
<a href="#michael-hayden">Michael Hayden</a>, Founder &amp; CEO, Prilenia Therapeutics; Killam Professor, University of British Columbia 
<a href="#mahmoud-pouladi">Mahmoud Pouladi</a> Associate Professor, Department of Medical Genetics, Faculty of Medicine, University of British Columbia 
<a href="#nik-subramanian">Nik Subramanian</a>, CTO &amp; Co-Founder, Kantify 
<a href="#gordon-wang">Gordon Wang</a>, Clinical Associate Professor, Department of Psychiatry &amp; Behavioral Sciences; Director, Neuroscience Microscopy Service, Wu Tsai Neurosciences Institute, Stanford University 
<a href="#xinyu-zhao">Xinyu Zhao</a>, Jenni and Kyle Professor, Waisman Center and Department of Neuroscience, University of Wisconsin-Madison

Innovation Showcase III: Drug Repurposing 

Fragile X Banner-final_40%

Fragile X Syndrome: Innovative Approaches to Finding a Cure

<a href="#hui-cai">Hui Cai</a>, Program Chair, VP &amp; Head of Content, WuXi AppTec 
<a href="#calaneet-balas">Calaneet Balas</a>, President &amp; CEO, The ALS Association 
<a href="#lin-kah-ooi">Lin Kah Ooi</a>, Founding President, Motor Neurone Disease Association Singapore

<a href="#carsten-bonnemann">Carsten Bönnemann</a>, Chief, Neuromuscular &amp; Neurogenetic Disorders of Childhood Section; Senior Investigator &amp; Acting Chief, Neurogenetics Branch, NINDS, NIH 
<a href="#matthew-harms">Matthew Harms</a>, Associate Professor of Neurology, Institute for Genomic Medicine, Columbia University 
Moderator: <a href="#sharon-hesterlee">Sharon Hesterlee</a>, Chief Research Officer, Muscular Dystrophy Association

The Unmet Needs in Neuromuscular Disorders 

<a href="#kuldip-dave">Kuldip Dave</a>, SVP of Research, The ALS Association 
<a href="#sabrina-paganoni">Sabrina Paganoni</a>, Co-Director, Neurological Research Institute at Massachusetts General Hospital; Physician Scientist, Healey &amp; AMG Center for ALS 
<a href="#jeffrey-rothstein">Jeffrey Rothstein</a>, Director of Brain Science Institute, Director, Robert Packard Center for ALS Research, Johns Hopkins University

Spotlight on ALS 

<a href="#neil-cashman">Neil Cashman</a>, CSO, ProMIS Neurosciences; Professor Emeritus, University of British Columbia 
<a href="#michael-mcgrath">Michael McGrath</a>, UCSF Emeritus Professor of Medicine; CSO &amp; Founder, Neuvivo 
<a href="#robert-scannevin">Robert Scannevin</a>, CSO, Verge Genomics 
<a href="#fernando-vieira">Fernando Vieira</a>, CEO &amp; CSO, ALS Therapy Development Institute 
Moderator: <a href="#murali-gopalakrishnan">Murali Gopalakrishnan</a>, Global Head, Neuroscience Search &amp; Evaluation, Corporate Strategy Office, AbbVie

In the Pipeline 

<a href="#jim-burns">Jim Burns</a>, CEO, Locanabio 
<a href="#clive-svendsen">Clive Svendsen</a>, Professor &amp; Executive Director, Board of Governors Regenerative Medicine Institute 
Moderator: <a href="#bibhash-mukhopadhyay">Bibhash Mukhopadhyay</a>, Managing Partner, Sound Bioventures

Challenges and Opportunities in New Modalities 

<a href="#michael-snyder">Michael Snyder</a>, Professor &amp; Chair, Department of Genetics; Director, Center for Genomics and Personalized Medicine, Stanford University

The Future of Genetic and Personalized Medicines 

Closing Remarks 

ALS-banner

Moving the Needle on ALS & Neuromuscular Disorders

<a href="#hui-cai">Hui Cai</a>, Program Chair, VP &amp; Head of Content, WuXi AppTec 
<a href="#steve-yang">Steve Yang</a>, Co-CEO, WuXi AppTec

Welcome & Opening Remarks 

A conversation between <a href="#sir-menelas-pangalos">Sir Menelas Pangalos</a>, EVP &amp; President, BioPharmaceuticals R&amp;D, AstraZeneca, and <a href="#steve-yang">Steve Yang</a>, Co-CEO, WuXi AppTec

Chronic Diseases: Rising to the Challenge

A conversation between <a href="#emilio-emini">Emilio Emini</a>, CEO, Bill &amp; Melinda Gates Medical Research Institute, and<a href="#zina-affas-besse"> Zina Affas Besse</a>, Deputy Head, Healthcare Private Equity, AXA Investment Managers Group

Global Health: From Partnership to Worldwide Access

<a href="#walter-koroshetz">Walter Koroshetz</a>, Director, National Institute of Neurological Disorders &amp; Stroke, National Institutes of Health

Call to Action: The Neuro Challenge

A conversation between <a href="#mariell-jessup">Mariell Jessup</a>, Chief Science &amp; Medical Officer, American Heart Association, and <a href="#faiez-zannad">Faiez Zannad</a>, Emeritus Professor of Therapeutics &amp; Cardiology, Université de Lorraine, Inserm; Chairman, CVCT, Paris, France

Call to Action: The Cardiovascular Challenge

A conversation between <a href="#harold-burstein">Harold Burstein</a>, Institute Physician, Dana-Farber Cancer Institute; Professor of Medicine, Harvard Medical School, <a href="#arif-kamal">Arif Kamal</a>, Chief Patient Officer, American Cancer Society; Physician Quality &amp; Outcomes Officer, Duke Cancer Institute, and <a href="#tony-mok">Tony Mok</a>, Li Shu Fan Professor of Clinical Oncology, The Chinese University of Hong Kong

Call to Action: The Cancer Challenge 

<a href="#erin-duffy">Erin Duffy</a>, Chief of Research &amp; Development, CARB-X 
<a href="#valeria-gigante">Valeria Gigante</a>, Team Lead, AMR Division, World Health Organization, Geneva, Switzerland 
<a href="#timothy-jinks">Timothy Jinks</a>, Head of Infectious Diseases Interventions, The Wellcome Trust 
<a href="#henry-skinner">Henry Skinner</a>, CEO, AMR Action Fund 
Session Leader: <a href="#jenny-yip">Jenny Yip</a>, Managing Partner, Adjuvant Capital

Spotlight on Antimicrobial Resistance 

<a href="#richard-soll">Richard Soll</a>, Head of Boston Office &amp; Senior Advisor of Strategic Initiatives, WuXi AppTec 
<a href="#minzhang-chen">Minzhang Chen</a>, Co-CEO, WuXi AppTec

Welcome & Opening Remarks

<a href="#stephen-hahn">Stephen Hahn</a>, CEO-Partner, Flagship Pioneering; CEO, Harbinger Health

Better. Faster. Smarter. 

<a href="#laurence-barker">Laurence Barker</a>, Partner, The Dementia Discovery Fund 
<a href="#christina-isacson">Christina Isacson</a>, Partner, Lightstone Ventures 
<a href="#philip-scheltens">Philip Scheltens</a>, Head, Dementia Fund, EQT Life Sciences 
Session Leader: <a href="#rana-al-hallaq">Rana Al-Hallaq</a>, Partner, Pfizer Ventures
&nbsp;

Moving the Needle on Neurological Disorders 

A conversation between <a href="#todd-sherer">Todd Sherer</a>, EVP, Research Strategy, The Michael J. Fox Foundation for Parkinson&#8217;s Research, and <a href="#andrew-siderowf">Andrew Siderowf</a>, Hurtig-Stern Professor in Neurology, University of Pennsylvania Perelman School of Medicine

Spotlight on Parkinson's Disease

<a href="#sekar-kathiresan">Sekar Kathiresan</a>, CEO, Verve Therapeutics 
<a href="#michael-mendelsohn">Michael Mendelsohn</a>, Founder &amp; Chairman, Cardurion Pharmaceuticals 
<a href="#christopher-de-souza">Christopher de Souza</a>, Director, Broadview Ventures 
<a href="#claudia-ulbrich">Claudia Ulbrich</a>, CEO &amp; Co-Founder, Cardior Pharmaceuticals 
Session Leader: <a href="#simone-fishburn">Simone Fishburn</a>, VP &amp; Editor in Chief, BioCentury Inc.

Revitalizing Cardiovascular R&D 

<a href="#rajesh-chopra">Rajesh Chopra</a>, Venture Partner, Head of Oncology, Apple Tree Partners 
<a href="#adam-friedman">Adam Friedman</a>, President, Corporate Strategy &amp; Business Development, Scorpion Therapeutics 
<a href="#luba-greenwood">Luba Greenwood</a>, CEO, Kojin Therapeutics 
<a href="#kt-moortgat">KT Moortgat</a>, Healthcare Venture Investor, Investment Partner, Droia Ventures 
<a href="#lewis-williams">Lewis Williams</a>, Co-founder, Chairman &amp; CEO, Walking Fish Therapeutics, Inc. 
Session Leader: <a href="#dave-madge">Dave Madge</a>, VP of Discovery Services, WuXi AppTec
&nbsp;

Reaching the Next Frontiers in Cancer Therapies

<a href="#jocelyne-bath">Jocelyne Bath</a>, Managing Director, OXGENE 
<a href="#richard-connell">Richard Connell</a>, SVP &amp; US/EU COO, WuXi AppTec

A conversation between <a href="#william-hait">William Hait</a>, EVP, Chief External Innovation, Medical Safety &amp; Global Public Health Officer, Johnson &amp; Johnson, and <a href="#julie-grant">Julie Grant</a>, General Partner, Canaan

Healthcare 2030: Current and Future Drivers of Success

<a href="#andrew-bruce">Andrew Bruce</a>, CEO, MediSix Therapeutics 
<a href="#wee-joo-chng">Wee Joo Chng</a>, Executive Director, Singapore Translational Cancer Consortium; Director &amp; Senior Consultant, National University Cancer Institute, Singapore, NUHS 
<a href="#boon-tong-koh">Boon Tong Koh</a>, Executive Director, Bioprocessing Technology Institute, A*STAR, Singapore 
<a href="#francesca-lim">Francesca Lim</a>, Assistant Medical Director, Cell Therapy Facility, Health Science Authority (HSA); Senior Consultant Hematologist, Singapore General Hospital 
<a href="#yann-chong-tan">Yann Chong Tan</a>, Managing Director, EVX Ventures; CEO, Nuevocor; CSO, Cargene Therapeutics 
Session Leader: <a href="#danny-soon">Danny Soon</a>, CEO, Consortium for Clinical Research &amp; Innovation, Singapore; Executive Director, Singapore Clinical Research Institute

Spotlight on Singapore: The Asia-Pacific Translation Hub for Cell and Gene Therapy in Oncology

Opening Remarks by <a href="#steve-bates">Steve Bates</a>, CEO, UK BioIndustry Association 
<a href="#billy-boyle">Billy Boyle</a>, Co-Founder &amp; CEO, Owlstone Medical 
<a href="#ryan-cawood">Ryan Cawood</a>, CSO, WuXi Advanced Therapies &amp; OXGENE 
<a href="#kathryn-corzo">Kathryn Corzo</a>, COO, bit.bio 
<a href="#jack-o'meara">Jack O&#8217;Meara</a>, CEO, Ochre Bio 
Session Leader: <a href="#michael-ward">Michael Ward</a>, Global Head of Life Sciences &amp; Healthcare Thought Leadership, Clarivate

Spotlight on UK: The Life Science Cluster Standing on the Shoulders of Giants

<a href="#vinteeta-agarwala">Vineeta Agarwala</a>, General Partner, Andreessen Horowitz 
<a href="#rohit-chandra">Rohit Chandra</a>, Chief Digital Officer, Cleveland Clinic 
<a href="#daphne-koller">Daphne Koller</a>, CEO &amp; Founder, insitro 
Session Leader: <a href="#ben-robbins">Ben Robbins</a>, Venture Partner, GV

When Technology Meets Healthcare

WHF2022 Banner_final_2MP

WuXi Healthcare Forum 2022

<a href="#steve-yang">Steve Yang</a>, Co-CEO, WuXi AppTec
<a href="#frederick-chew">Frederick Chew</a>, CEO, A*STAR; Chief, Public Sector Science &amp; Technology Policy &amp; Plans Office, Prime Minister’s Office of Singapore
<a href="#george-vradenburg">George Vradenburg</a>, Convener, The Global CEO Initiative on Alzheimer’s Disease; Founding Chairman, Davos Alzheimer’s Collaborative; Chairman &amp; Co-Founder, UsAgainstAlzheimer’s

Opening Remarks

<a href="#kate-bingham">Kate Bingham</a>, Managing Partner, SV Health Investors
<a href="#luigi-ferrucci">Luigi Ferrucci</a>, Scientific Director, National Institute on Aging of NIH
<a href="#paul-irving">Paul Irving</a>, Chairman, Milken Institute Center for the Future of Aging; Distinguished Scholar-in-Residence, USC Davis School of Gerontology
Session Leader:  <a href="#michal-preminger">Michal Preminger</a>, Regional Head, Johnson &amp; Johnson Innovation East North America

Aging: The Grand Challenge

<a href="#niranjan-bose">Niranjan Bose</a>, Managing Director, Health &amp; Life Sciences, Gates Ventures
<a href="#ivan-cheung">Ivan Cheung</a>, Chairman, Eisai Inc; Global President of Neurology Business Group, Eisai Co Ltd
<a href="#george-vradenburg">George Vradenburg</a>, Convener, The Global CEO Initiative on Alzheimer’s Disease; Founding Chairman, Davos Alzheimer’s Collaborative; Chairman &amp; Co-Founder, UsAgainstAlzheimer’s
Session Leader:  <a href="#stacie-weninger">Stacie Weninger</a>, President of F-Prime Biomedical Research Initiative (FBRI)

Spotlight on Alzheimer’s Disease

<a href="#linda-partridge">Linda Partridge</a>, Founding Director, Max Planck Institute for Biology of Ageing; Professor, Institute of Healthy Ageing, and GEE, UCL
<a href="#eric-verdin">Eric Verdin</a>, CEO &amp; President, Buck Institute for Research on Aging
Session Leader: <a href="#sebastien-thuault">Sebastien Thuault</a>, Chief Editor, Nature Aging

State of Aging Research

<a href="#yap-seng-chong">Yap-Seng Chong</a>, Dean, NUS Yong Loo Lin School of Medicine; Chief Clinical Officer, A*STAR
<a href="#daniel-fung">Daniel Fung</a>, CEO, Institute of Mental Health in Singapore
<a href="#chien-earn-lee">Chien-Earn Lee</a>, Deputy Group CEO (Regional Health System), SingHealth
<a href="#andrea-maier">Andrea Maier</a>, Co-Director, Centre for Healthy Longevity, National University Health System, Singapore
Session Leader: <a href="#brian-kennedy">Brian Kennedy</a>, Distinguished Professor in Biochemistry and Physiology, the Yong Loo Lin School of Medicine, National University of Singapore

Healthy Aging: Singapore’s Perspectives 

A conversation between <a href="#scott-berkowitz">Scott Berkowitz</a>, VP &amp; Chief Population Health Officer, Johns Hopkins Medicine; Associate Professor of Cardiology, Johns Hopkins University and <a href="#henry-brodaty">Henry Brodaty</a>, Professor of Ageing and Mental Health; Co-Director, CHeBA (Centre for Healthy Brain Ageing), UNSW Sydney

Prevention. Prediction. Personalization.

<a href="#rita-balice-gordon">Rita Balice-Gordon</a>, CEO, Muna Therapeutics
<a href="#marco-boorsma">Marco Boorsma</a>, General Partner at Forbion
<a href="#jens-eckstein">Jens Eckstein</a>, Managing Partner, Apollo Health Ventures
<a href="#kristen-fortney">Kristen Fortney</a>, Co-Founder and CEO, BioAge
<a href="#james-peyer">James Peyer</a>, Founder &amp; CEO, Cambrian Biopharma
Session Leader: <a href="#dave-madge">Dave Madge</a>, VP of Discovery Services, WuXi AppTec

The Next Frontiers in Tackling Age-Related Disorders

<a href="#joseph-coughlin">Joseph Coughlin</a>, Founder and Director, MIT AgeLab

How Will Technologies Shape the New Era of Healthy Aging

Closing 

Astar Banner-new v4_website

Rising to the Challenge: Healthy Aging Forum 2022

<a href="#minzhang-chen">Minzhang Chen</a>, Co-CEO, WuXi AppTec

Opening Remarks 

<a href="#david-berry">David Berry</a>, Founder and CEO, Valo Health
<a href="#diego-miralles">Diego Miralles</a>, CEO, Laronde
<a href="#roger-perlmutter">Roger Perlmutter</a>, Chairman &amp; CEO, Eikon Therapeutics
<a href="#henrijette-richter">Henrijette Richter</a>, Managing Partner, Sofinnova Partners
Session Leader: <a href="#jorge-conde">Jorge Conde</a>, General Partner, Andreessen Horowitz

Opening Plenary: Changing the Games of R&D Productivity 

A Conversation between <a href="#susan-galbraith">Susan Galbraith</a>, EVP, Oncology R&amp;D, AstraZeneca and <a href="#david-reese">David Reese</a>, EVP of R&amp;D, Amgen

A Special Tribute to Dr. José Baselga 

A Conversation with <a href="#james-wilson">James Wilson</a>, Professor of Medicine and Pediatrics of Department of Medicine, and Director of Gene Therapy Program, University of Pennsylvania. Moderated by <a href="#john-carroll">John Carroll</a>, Chief Editor &amp; Founder, Endpoints News

A Special Tribute to Dr. Tachi Yamada 

<a href="#christiana-bardon">Christiana Bardon</a>, Co-Managing Partner of BioImpact Capital, MPM Capital
<a href="#Jürgen-eckhardt">Jürgen Eckhardt</a>, SVP and Head of Leaps by Bayer
<a href="#alice-pomponio">Alice Pomponio</a>, Managing Director, American Cancer Society BrightEdge
<a href="#glenn-rockman">Glenn Rockman</a>, Founder and Managing Partner, Adjuvant Capital
Session Leader: <a href="#laura-kleiman">Laura Kleiman</a>, Founder and CEO, Reboot Rx

Investing for Social Impact

<a href="#debora-barton">Debora Barton</a>, CMO, Carisma Therapeutics
<a href="#john-houston">John Houston</a>, President and CEO, Arvinas
<a href="#eric-kelsic">Eric Kelsic</a>, Founder &amp; CEO, Dyno Therapeutics
<a href="#devyn-smith">Devyn Smith</a>, CEO, Arbor Biotechnologies
Session Leader: <a href="#ryan-cawood">Ryan Cawood</a>, CSO, WuXi Advanced Therapies and OXGENE

Delivering on the Promise of New Modalities

A Conversation with <a href="#todd-golub">Todd Golub</a>, Director, Broad Institute of MIT &amp; Harvard. Moderated by <a href="#kevin-davies">Kevin Davies</a>, Executive Editor, The CRISPR Journal and GEN Biotechnology; and Author, Editing Humanity

Events

UPCOMING EVENT

WuXi Global Forum 2023

WuXi Global Forum

EVENT RECAP

Mental Health R&D: A Global Priority

Events

EVENT RECAP

Fragile X Syndrome: Innovative Approaches to Finding a Cure

Events, Rare Disease

EVENT RECAP

Moving the Needle on ALS & Neuromuscular Disorders

Events

EVENT RECAP

WuXi Healthcare Forum 2022

Events

Rising to the Challenge: Healthy Aging Forum 2022

Events

WuXi Global Forum 2022

WuXi Global Forum

Episode I: Tackling Alzheimer’s Disease with Scale, System & Speed

Events

Featured

Fragile X Syndrome: Innovative Approaches to Finding a Cure

Events, Rare Disease

Moving the Needle on ALS & Neuromuscular Disorders

Events

WuXi Healthcare Forum 2022

Events

Rising to the Challenge: Healthy Aging Forum 2022

Events

WuXi Global Forum 2022

WuXi Global Forum

Live Now! Join Global Leaders for “Dialogues on Healthy Aging”

Events